Original Versus Generic Lenalidomide in Patients with Relapsed/ Refractory Multiple Myeloma: Comparison of Efficacy and Adverse Events

Original Versus Generic Lenalidomide in Patients with Relapsed/ Refractory Multiple Myeloma: Comparison of Efficacy and Adverse Events

Objective: Lenalidomide is an effective immunomodulatory derivative drug used in the treatment of multiple myeloma (MM). It is available in original and generic forms in Turkey, but there is no clinical study that has compared the effectiveness and adverse events (AEs) of the generic and original fo...

Full description

Bibliographic Details
Main Authors: Ali Zahit Bolaman, Atakan Turgutkaya, Birsen Sahip, Cem Selim, Ayşe Hilal Eroğlu Küçükdiler, Şehmus Ertop, Gökhan Sargın, İrfan Yavaşoğlu
Format: Article
Language:English
Published: Galenos Publishing House 2021-02-01
Series:Turkish Journal of Hematology
Subjects:
lenalidomide
treatment
original
generic
adverse effect
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-45804

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-45804

Similar Items